TrialClinical and translational science2019

CYP2B6 Genotype-Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers.

Ingrid F Metzger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.